• Users Online: 151
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2021  |  Volume : 18  |  Issue : 3  |  Page : 204-207

Serum ghrelin level in type 2 diabetes mellitus postmenopausal women in relation to body mass index


1 Department of Biochemistry, College of Medicine, University of Baghdad, Al-Hilla City, Babylon Province, Iraq
2 Department of Clinical Biochemistry, College of Medicine, University of Baghdad, Baghdad City, Iraq
3 Department of Pathology, College of Medicine, University of Baghdad, Baghdad City, Iraq

Correspondence Address:
Amal Abdulhussein Matrood
Department of Biochemistry, College of Medicine, University of Baghdad, Al-Hilla City, Babylon Province.
Iraq
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/MJBL.MJBL_4_21

Get Permissions

Background: People living with type 2 diabetes mellitus (DM) are more vulnerable to various forms of both short- and long-term complications, which often lead to their premature death. Objectives: The aim of this study was to evaluate the effects of serum level of ghrelin in diabetic postmenopausal, nondiabetic obese menopausal, and control healthy women. Materials and Methods: This case–control study included 90 participants (30 diabetic postmenopausal women, 30 nondiabetic obese menopausal women with body mass index (BMI) equal or >30, and 30 control healthy participants). Full history for referred individuals was taken and height and body weight were measured. BMI <18.5 was considered underweight, between 18.5 and 24.9 was a normal, between 25 and 29.9 was overweight, and more than 30 was obese. Results: Age ranged between 45 and 80 years old. Serum ghrelin had highly significant difference in obese comparison to both diabetes and control groups, and there is a significant difference between obese and diabetes with higher concentration in obese than diabetic group. Mean fasting blood glucose (FBG) showed a highly significant difference between obese, diabetes, and control groups with higher concentration in both obese and diabetes participants, and specifically, there is a significant difference between diabetes and obese groups with higher concentration in diabetic than obese group. BMI showed a significant difference and higher level in obese in comparison to other two groups. The serum ghrelin had a moderate significant correlation with FBG in obese but insignificant correlation with both diabetes and control groups. FBG shows no significant correlation with BMI in all three groups. Conclusion: There is an inverse relationship between fasting glucose and ghrelin level in type 2 diabetic patients and positive correlation in obesity. The study also shows that hyperglycemia due to disturbance in glucose metabolism may result in suppression of ghrelin level in type 2 DM.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed162    
    Printed8    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal